BOSTON ONCOLOGY ARABIA and LOCAL CONTENT & GOVERNMENT PROCUREMENT AUTHORITY Sign Agreement to Localize Advanced Biologic Medicines in Saudi Arabia
4.11.2025 20:50:00 EET | Business Wire | Press release
In a major step toward advancing pharmaceutical local content and national drug security, BOSTON ONCOLOGY ARABIA and the Local Content & Government Procurement Authority (LCGPA) have signed an agreement to localize the manufacture of two biosimilar medicines within the Kingdom.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251104239476/en/
Representatives from the Local Content & Government Procurement Authority (LCGPA) and Boston Oncology Arabia at the Global Health Exhibition 2025 in Riyadh, following the signing of an agreement to localize the manufacturing of advanced biologic medicines. The partnership builds on Boston Oncology Arabia’s fully integrated Saudi operations and its leadership in transferring global biopharma expertise to strengthen national drug security, expand local value creation, and deliver sustainable access to high-quality biologic therapies in line with Vision 2030.
The signing ceremony took place at the Global Health Exhibition, under the auspices of the Ministry of Health and the Local Content & Government Procurement Authority, underscoring the Kingdom’s commitment to strengthening local manufacturing capabilities and ensuring reliable access to essential biologic therapies for patients nationwide.
Strengthening National Drug Security
Through this agreement, Boston Oncology Arabia will lead the technology transfer, local manufacturing, and commercial rollout of two high-value biologics — adalimumab and etanercept — used in the treatment of autoimmune and inflammatory diseases such as rheumatoid arthritis and psoriasis. The initiative contributes to the continued expansion of the Kingdom’s pharmaceutical local content portfolio and advances Vision 2030’s objectives for healthcare transformation and industrial self-sufficiency.
“This signing represents a defining moment in the localization of complex biologics,” said Dr. Abdullah Baaj, Founder & CEO of Boston Oncology Arabia. “By manufacturing adalimumab and etanercept domestically, we are not only expanding access to life-changing biologic therapies, but also building a sustainable foundation for Saudi self-reliance in advanced pharmaceutical production.”
Eng. Abdulrahman bin Ibrahim Alsagheir, LCGPA’s Official Spokesperson, stated that “these agreements are expected to generate an estimated economic impact exceeding SAR 1.2 billion on the national GDP and create around 500 direct jobs to qualify Saudi talent in the healthcare and pharmaceutical sectors.”
A Milestone for Localized Biologic Manufacturing
Boston Oncology Arabia has been at the forefront of Saudi Arabia’s pharmaceutical local content strategy, with an expanding portfolio of advanced generics, biosimilars, peptides, and critical-care injectables designed to meet national demand across high-impact therapeutic areas. The company’s state-of-the-art manufacturing facility in Sudair Industrial City operates to USFDA, EMA, and SFDA standards, ensuring that every locally made product meets the highest international benchmarks for quality and safety.
The localization of these advanced biologics further solidifies Boston Oncology Arabia’s role as a national leader in biologic manufacturing, enabling faster, more reliable access to critical medicines and supporting the Kingdom’s long-term objective of pharmaceutical independence.
About Boston Oncology Arabia
Headquartered in Riyadh, Boston Oncology Arabia is a fully integrated pharmaceutical company purpose-built for localization. The company develops, manufactures, and commercializes advanced generics, biosimilars, peptides, and critical-care injectables to meet the highest global standards while serving the real-world needs of Saudi hospitals.
With operations anchored in Sudair Industrial City, Boston Oncology Arabia supports the goals of Vision 2030 by strengthening national drug security and expanding the Kingdom’s capacity for high-value, technology-driven pharmaceutical production. Its end-to-end model—spanning licensing, local development, manufacturing, and commercialization—ensures a reliable supply of world-class medicines that reach patients swiftly, safely, and affordably.
Learn more at https://bostononcology.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20251104239476/en/
Contacts
For further information, please contact Boston Oncology Arabia Public Relations:
media@bostononcology.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Wasabi Establishes AI Business in Silicon Valley, Taps Pinaki Mukherjee to Lead as Senior Vice President & General Manager10.9.2026 16:00:00 EEST | Press release
Wasabi Technologies, the hot cloud storage company, today announced the formation of a dedicated AI business, and the appointment of semiconductor and storage veteran Pinaki Mukherjee as senior vice president and general manager to lead it. Wasabi stores hundreds of petabytes of AI data for frontier model labs, generative AI startups, and neocloud compute providers worldwide. This new AI business brings dedicated strategy, partnerships and go-to-market focus for this demand as AI infrastructure matures. “Mukherjee has a track record of driving the kind of high-value partnerships that move markets, and that’s exactly what this moment requires,” said Marty Falaro, president and COO of Wasabi. “AI workloads are pushing storage demand to a scale we've never seen, and Mukherjee is the right person to build the partnerships that extend Wasabi's position as the industry's choice for cloud storage, at the exact moment inference is reshaping what that storage needs to do.” Proven leadership in
Ant Group’s AI Health App AQ Reaches 150 Million Users as It Expands AI-powered Day-to-day Health Use Cases10.9.2026 15:47:00 EEST | Press release
At the 2026 INCLUSION · Conference on the Bund in Shanghai, Zhang Junjie, Vice President of Ant Group and Head of the Health Business, announced that Ant Group’s flagship AI health app AQ has reached 150 million users, handling nearly 20 million health inquiries per day. The new milestone also means AQ has grown its user base by 50% in just 8 months, since it announced 100 million users in February 2026, reflecting strong demand in China’s AI health space. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260910921103/en/ Ant Group’s AI health app AQ provides personalized health advice based on more than 10 health indicators. Health has become an increasingly important priority among Chinese consumers. According to Accenture’s China Consumer Insights report published in November 2025, the share of Chinese consumers who considered health a priority increased from 78% in 2021 to 87% in 2025, making it the top priority among the a
AULUMU Introduces A18 Series for iPhone 18 With Aramid Fibre, Hybrid Protection and Distinctive Finishes10.9.2026 15:43:00 EEST | Press release
Technology accessories brand aulumu has introduced the A18 Series for iPhone 18, a new collection of smartphone cases designed around lightweight protection, material innovation and distinctive visual finishes. The range includes the A18 Armor Shockproof Aramid Fiber Case, two ultra-slim aramid fibre models, the Ghost Lumen Transparent Case, and the Particle Vegan Leather Case. At the centre of the collection, the A18 Armor combines 1500D aramid fibre and thermoplastic polyurethane (TPU) in a one-piece construction. The hybrid structure pairs the light weight and woven texture of aramid fibre with the flexibility and cushioning properties of TPU. A full-wrap design covers the phone’s edges, while reinforced corners are intended to help distribute impact from everyday drops and bumps. The case is designed to provide drop protection from heights of up to 2 metres, with a 1.36 mm raised screen edge and a 1.3 mm raised camera frame providing additional protection around key areas. The A18
BGC Group Announces its First-Ever Fully AI Brokered Institutional Trade in Listed Equity Derivatives10.9.2026 15:30:00 EEST | Press release
BGC Group Inc. (Nasdaq: BGC) (“BGC”), a leading global brokerage and financial technology company servicing financial markets, today announced it has launched Fenics AI, and that its subsidiary, Aurel BGC, has completed its first-ever fully AI brokered institutional trade in listed equity derivatives, using autonomous AI-powered systems to manage the trading workflow from price discovery through to execution. Fenics AI, BGC’s new proprietary AI trading technology, arranged this landmark transaction on September 3, 2026, in Eurex listed Swiss SMI options between two institutional accounts, including Hudson Bay Capital. This successful first AI trade follows rigorous development and testing to ensure compatibility with applicable market conventions, rules and governance. Fenics AI is expected to be made available to BGC’s clients during the fourth quarter 2026 to deliver significant efficiencies across the trade lifecycle, including price discovery, execution, trade processing, and settl
Coulson Aviation Defines the Next Chapter of Innovation With EmberWorks10.9.2026 15:03:00 EEST | Press release
Coulson Aviation is moving forward with EmberWorks, its dedicated innovation division created to turn real-world operational challenges into new capabilities for aerial firefighting, aviation, and emergency response. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260910644135/en/ Comparison imagery demonstrates how ORBIT uses airborne thermal sensing and automated processing to identify wildfire activity and generate geolocated fire intelligence. First introduced at the Aerial Fire Fighting Global Conference in Rome earlier this year, EmberWorks formalizes an approach to innovation that has existed throughout Coulson’s history. From aircraft modification and mission-system development to programs such as C-130 airtanker, Boeing 737 Fireliner, and CH-47 Chinook helicopter, Coulson has long developed solutions in response to real-world operational needs. EmberWorks builds on that history by giving this approach a dedicated str
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom